A series of arene ruthenium(ii) complexes withN-monodentate (AAP) andN,O- andN,N-bidentate chelating ligands (AAPS, ADABS, AAPPA and P2P) have been synthesized and evaluated for preliminary antileukemia activity against K562 (Human chronic myeloid leukemia cell line).
一系列含有N-一齿(AAP)和N-一齿、O-双齿、N-双齿螯合配体(AAPS、ADABS、AAPPA和P2P)的芳烃钌(II)配合物已被合成,并对其针对K562(人类慢性髓性白血病细胞系)的初步抗白血病活性进行了评估。